Now, a team at Stanford University has demonstrated that a cancer vaccine made from induced pluripotent stem cells (iPSCs), together with an immune adjuvant, could protect against pancreatic cancer in mouse models. The findings were published in the journal Stem Cell Reports. Read more . . .
Cancer vaccines that prime the immune system to recognize and eliminate cancer cells have gained traction lately. Scientists are pursuing a wide range of strategies including making vaccines from immune cells, tumor cells, tumor-associated proteins or their smaller components.